Resultados da pesquisa - Yang Weizhu
- A mostrar 1 - 20 resultados de 24
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2... Por Megaraj, Vandana, Zhou, Xin, Xie, Fang, Liu, Zhihua, Yang, Weizhu, Ding, Xinxin
Publicado em 2014Text -
7
-
8
-
9
-
10
A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma Por Yan, Leye, Lin, Junqing, Ke, Kun, Wu, Zhengzhong, Huang, Jingyao, Huang, Ning, Yang, Weizhu
Publicado em 2022Text -
11
Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity Por Fang, Cheng, Gu, Jun, Xie, Fang, Behr, Melissa, Yang, Weizhu, Abel, E. Dale, Ding, Xinxin
Publicado em 2008Text -
12
-
13
Generation of a Mouse Model with a Reversible Hypomorphic Cytochrome P450 Reductase Gene: Utility for Tissue-Specific Rescue of the Reductase Expression, and Insights from a Result... Por Wei, Yuan, Zhou, Xin, Fang, Cheng, Li, Lei, Kluetzman, Kerri, Yang, Weizhu, Zhang, Qing-Yu, Ding, Xinxin
Publicado em 2010Text -
14
Deficits in Neuronal Cytochrome P450 Activity Attenuate Opioid Analgesia but not Opioid Side Effects Por Hough, Lindsay B., Nalwalk, Julia W., Cleary, Rachel A., Phillips, James G., Fang, Cheng, Yang, Weizhu, Ding, Xinxin
Publicado em 2014Text -
15
-
16
Mechanism of chloroform-induced renal toxicity: Non-involvement of hepatic cytochrome P450-dependent metabolism Por Fang, Cheng, Behr, Melissa, Xie, Fang, Lu, Shijun, Doret, Meghan, Luo, Hongxiu, Yang, Weizhu, Aldous, Kenneth, Ding, Xinxin, Gu, Jun
Publicado em 2007Text -
17
Large-deformation and high-strength amorphous porous carbon nanospheres Por Yang, Weizhu, Mao, Shimin, Yang, Jia, Shang, Tao, Song, Hongguang, Mabon, James, Swiech, Wacek, Vance, John R., Yue, Zhufeng, Dillon, Shen J., Xu, Hangxun, Xu, Baoxing
Publicado em 2016Text -
18
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study Por Zhi‐Cheng Jin, Bin‐Yan Zhong, Jian-Jia Chen, Hai‐Dong Zhu, Jun‐Hui Sun, Guowen Yin, Naijian Ge, Biao Luo, Wen‐Bin Ding, Wenhui Li, Li Chen, Yu-Qing Wang, Xiaoli Zhu, Yang Weizhu, H. Li, Gao‐Jun Teng
Publicado em 2023Artigo -
19
Brain P450 Epoxygenase Activity is Required for the Antinociceptive Effects of Improgan, a Non-Opioid Analgesic Por Hough, Lindsay B., Nalwalk, Julia W., Yang, Jun, Conroy, Jennie L., VanAlstine, Melissa A., Yang, Weizhu, Gargano, Joseph, Shan, Zhixing, Zhang, Shao-Zhong, Wentland, Mark P, Phillips, James G., Knapp, Brian I., Bidlack, Jean M., Zuiderveld, Obbe P., Leurs, Rob, Ding, Xinxin
Publicado em 2011Text -
20
Opioids Activate Brain Analgesic Circuits Through Cytochrome P450/Epoxygenase Signaling Por Conroy, Jennie L., Fang, Cheng, Gu, Jun, Zeitlin, Scott O., Yang, Weizhu, Yang, Jun, VanAlstine, Melissa A., Nalwalk, Julia W., Albrecht, Phillip J., Mazurkiewicz, Joseph E., Snyder-Keller, Abigail, Shan, Zhixing, Zhang, Shao-Zhong, Wentland, Mark P., Behr, Melissa, Knapp, Brian I., Bidlack, Jean M., Zuiderveld, Obbe P., Leurs, Rob, Ding, Xinxin, Hough, Lindsay B.
Publicado em 2010Text
Ferramentas de pesquisa:
Assuntos relacionados
Hepatocellular carcinoma
Internal medicine
Medicine
Oncology
Confidence interval
Gastroenterology
Hazard ratio
Propensity score matching
Clinical trial
Combination therapy
Response Evaluation Criteria in Solid Tumors
Retrospective cohort study
Adverse effect
Antibody
Apatinib
Cancer
Cancer research
Chemotherapy
Clinical endpoint
Environmental health
Immune checkpoint
Immune system
Immunology
Immunotherapy
Lenvatinib
Overall survival
Phases of clinical research
Population
Progression-free survival
Progressive disease